When is the next results date for Vista Pharmaceuticals Ltd?
2026-05-20 23:17:41The next results date for Vista Pharmaceuticals Ltd is scheduled for 29 May 2026....
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-05-20 10:10:21Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 May 2026, providing investors with the latest insights into its performance and prospects.
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-05-07 10:10:27Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-04-26 10:10:13Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-04-15 10:10:17Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.
Read MoreOutcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-May-2026 | Source : BSEBoard meeting outcome
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSESEBI Secretarial Compliance Report for the year ended 31.03.2026
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2026
19-May-2026 | Source : BSEVista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2026 2. Audit Report for the quarter and year ended 31.03.2026 3. Any other business with the permission of the Chair.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available